Evidence map›Paper›PMID 28903769›Full record

ReviewTrials2017

Specific barriers to the conduct of randomised clinical trials on medical devices.

Edmund A M Neugebauer, Ana Rath, Sunya-Lee Antoine, Michaela Eikermann, Doerthe Seidel, Carsten Koenen, Esther Jacobs, Dawid Pieper, Martine Laville, Séverine Pitel and 8 more

Abstract readReview
In one paragraph

Review in Trials, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Health Technology Assessment in the Early Phases of Development of Medical Devices: A Catalyst for Sustainable Growth and Innovation.Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine · 2025
    Article
  14. Article
  15. Observational
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Edmund A M NeugebauerBrandenburg Medical School Theodor Fontane & Health Services Research Witten/Herdecke University, Campus Neuruppin, Neuruppin, Germany.
Ana RathOrphanet, Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France.
Sunya-Lee AntoineInstitute for Research in Operative Medicine, Witten/Herdecke University, Cologne, Germany.
Michaela EikermannInstitute for Research in Operative Medicine, Witten/Herdecke University, Cologne, Germany.
Doerthe SeidelInstitute for Research in Operative Medicine, Witten/Herdecke University, Cologne, Germany.
Carsten KoenenInstitute for Research in Operative Medicine, Witten/Herdecke University, Cologne, Germany.
Esther JacobsInstitute for Research in Operative Medicine, Witten/Herdecke University, Cologne, Germany.
Dawid PieperInstitute for Research in Operative Medicine, Witten/Herdecke University, Cologne, Germany.
Martine LavilleCentre de Recherche en Nutrition Humaine Rhone-Alpes, Université de Lyon 1, Hospices Civils de Lyon, Groupement Hospitaler Sud, Pierre Benite, France.
Séverine PitelQUALISSIMA, 10 Rue Clapier, Marseille, France.
Cecilia MartinhoAIBILI, Azinhaga de Santa Comba-Celas, Coimbra, Portugal.
Snezana DjurisicCopenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. sd@ctu.dk.ORCID 0000-0001-8259-8250
Jacques Demotes-MainardEuropean Clinical Research Infrastructure Network (ECRIN), Paris, France.
Christine KubiakEuropean Clinical Research Infrastructure Network (ECRIN), Paris, France.
Vittorio BerteleIRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Janus C JakobsenCopenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Silvio GarattiniIRCCS Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Christian GluudCopenhagen Trial Unit, Centre for Clinical Intervention Research, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark. cgluud@ctu.dk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMedical devices play an important role in the diagnosis, prevention, treatment and care of diseases. However, compared to pharmaceuticals, there is no rigorous formal regulation for demonstration of benefits and exclusion of harms to patients. The medical device industry argues that the classical evidence hierarchy cannot be applied for medical devices, as randomised clinical trials are impossible to perform. This article aims to identify the barriers for randomised clinical trials on medical devices.

methodsSystematic literature searches without meta-analysis and internal European Clinical Research Infrastructure Network (ECRIN) communications taking place during face-to-face meetings and telephone conferences from 2013 to 2017 within the context of the ECRIN Integrating Activity (ECRIN-IA) project.

resultsIn addition to the barriers that exist for all trials, we identified three major barriers for randomised clinical trials on medical devices, namely: (1) randomisation, including timing of assessment, acceptability, blinding, choice of the comparator group and considerations on the learning curve; (2) difficulties in determining appropriate outcomes; and (3) the lack of scientific advice, regulations and transparency.

conclusionsThe present review offers potential solutions to break down the barriers identified, and argues for applying the randomised clinical trial design when assessing the benefits and harms of medical devices.

Indexed as

Equipment and SuppliesResearch DesignEndpoint DeterminationHumansRandomized Controlled Trials as TopicRisk AssessmentTime FactorsTreatment OutcomeAssessmentEuropean Clinical Research Infrastructure NetworkEvidence-based clinical practiceEvidence-based medicineMedical devicesRandomised clinical trialsSpecific barriers

Identifiers

PMID28903769
PMCPMC5597993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.